Clinical outcomes following allogeneic transplantation for HLH
| Clinical Outcome . | Estimate, % (95% CI) . |
|---|---|
| aGVHD | |
| Grade 2-4 at 6 mo | 29 (11-49) |
| Grade 2-4 at 1 y | 38 (18-58) |
| Grade 3-4 at 6 mo | 9.5 (1.5-27) |
| cGVHD | |
| All cGVHD at 2 y | 52 (29-71) |
| Moderate/severe cGVHD at 2 y | 29 (11-49) |
| Relapse incidence at 3 y | 15 (3.4-33) |
| Nonrelapse mortality at 3 y | 15 (3.5-34) |
| PFS at 3 y | 71 (46-86) |
| OS at 3 y | 75 (51-89) |
| Clinical Outcome . | Estimate, % (95% CI) . |
|---|---|
| aGVHD | |
| Grade 2-4 at 6 mo | 29 (11-49) |
| Grade 2-4 at 1 y | 38 (18-58) |
| Grade 3-4 at 6 mo | 9.5 (1.5-27) |
| cGVHD | |
| All cGVHD at 2 y | 52 (29-71) |
| Moderate/severe cGVHD at 2 y | 29 (11-49) |
| Relapse incidence at 3 y | 15 (3.4-33) |
| Nonrelapse mortality at 3 y | 15 (3.5-34) |
| PFS at 3 y | 71 (46-86) |
| OS at 3 y | 75 (51-89) |